Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
NCT07551479 Oxaliplatin Locally Advanced Rectal Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07551479 clinical trial report covering Oxaliplatin, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
6 min read
Adalimumab Biologics Sequence Review Report 2026: TNF Similarity and Patent-Risk Signals
22 July 2026
Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Adalimumab, an antibody targeting TNF.
Latest Hotspot
8 min read
NCT07549412 Precemtabart tocentecan Metastatic Colorectal Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07549412 clinical trial report covering Precemtabart tocentecan, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20261536 Ketoprofen Tenosynovitis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
CTR20261536 clinical trial report covering Ketoprofen, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07549399 Cetuximab Rectal Adenocarcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07549399 clinical trial report covering Cetuximab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07551492 Ribupatide Atherosclerosis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07551492 clinical trial report covering Ribupatide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20261636 Interferon alpha-2b(Anhui Anke Biotechnology) Herpangina Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
CTR20261636 clinical trial report covering Interferon alpha-2b(Anhui Anke Biotechnology), Phase 3, endpoints, sponsor, geography, readout timing and developme
Latest Hotspot
8 min read
NCT07552389 HL-1113 Diabetes Mellitus, Type 2 Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07552389 clinical trial report covering HL-1113, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07553182 Filgotinib Maleate Juvenile Idiopathic Arthritis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07553182 clinical trial report covering Filgotinib Maleate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07552597 Technetium (99mTc) Pyrophosphate Melanoma, Cutaneous Malignant Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07552597 clinical trial report covering Technetium (99mTc) Pyrophosphate, Phase 3, endpoints, sponsor, geography, readout timing and development white spac
Latest Hotspot
8 min read
CTR20261498 Octreotide(CSPC Zhongqi) Acromegaly Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
CTR20261498 clinical trial report covering Octreotide(CSPC Zhongqi), Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07552987 Immune Globulin Intravenous, Human -kthm (Kedrion) Stiff-Person Syndrome Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07552987 clinical trial report covering Immune Globulin Intravenous, Human -kthm (Kedrion), Phase 3, endpoints, sponsor, geography, readout timing and deve